HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Autosomal Dominant 10 Deafness

Also Known As:

Deafness, Autosomal Dominant 10; DFNA10

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hearing Loss (Hearing Impairment)
2.	Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)
3.	Sensorineural Hearing Loss
4.	Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
5.	Autosomal Dominant 28 Deafness

Experts

1.	Choi, Byung Yoon: 1 article (05/2016)
2.	Choi, Hyun Seok: 1 article (05/2016)
3.	Kim, Ah Reum: 1 article (05/2016)
4.	Kim, Shin Hye: 1 article (05/2016)
5.	Arnesson, Hanna: 1 article (05/2015)
6.	Dahl, Niklas: 1 article (05/2015)
7.	Frykholm, Carina: 1 article (05/2015)
8.	Klar, Joakim: 1 article (05/2015)
9.	Lodahl, Marianne: 1 article (05/2015)
10.	Rehnman, Anna-Carin: 1 article (05/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Autosomal Dominant 10 Deafness:

1.	Proteins (Proteins, Gene)FDA Link 05/25/2015 - "The results imply that unidentified factors, genetic or environmental, other than the EYA4 mutation, are of importance for the age at onset of DFNA10, and that mutation early in the variable region of the EYA4 protein can occur in the absence of dilated cardiomyopathy." 09/01/2004 - "A comparative study of Eya1 and Eya4 protein function and its implication in branchio-oto-renal syndrome and DFNA10."
2.	Mutant Proteins (Protein, Mutant)IBA 05/01/2016 - "Mutations of this gene are known to cause postlingual and progressive sensorineural hearing loss, either as non-syndromic (DFNA10) or syndromic hearing loss, depending on the location of truncation of the mutant protein. "
3.	Transcription Factors (Transcription Factor)IBA 01/01/2015 - "Since EYA4 and GRHL2 were identified as the transcription factors for the DFNA10 and DFNA28, 8 EYA4 mutations and 2 GRHL2 mutations have been reported worldwide. "